Compound Detail
CHEMBL100831
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL100831 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KCMZCJPKBVPPJD-UHFFFAOYSA-N |
2
Targets
5
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
274.1
MW (Da)
0.19
ALogP
5
HBA
5
HBD
140.0
PSA (Ų)
0.49
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 7.74
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Farnesyl pyrophosphate synthase CHEMBL1782 | IC50 | 7.74 | 7.74 | 18.2 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.15 | 6.125 | 710.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Farnesyl pyrophosphate synthase | IC50 | = | 18.2 | nM | 7.74 | Negative logarithm of inhibitory concentration against bone resorption | 12825934 |
| Unchecked | IC50 | = | 710.0 | nM | 6.15 | Inhibition of Plasmodium vivax FPPS expressed in Escherichia coli BL21 by spectr... | 19053772 |
| Unchecked | IC50 | = | 794.33 | nM | 6.1 | Inhibition of Plasmodium vivax FPPS expressed in Escherichia coli BL21 by spectr... | 19053772 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12825934 | 10.1021/jm030054u | Farnesyl pyrophosphate synthase | 2 |
| 19053772 | 10.1021/jm8009074 | Unchecked | 2 |
| 19053772 | 10.1021/jm8009074 | Plasmodium falciparum | 2 |
| 12166945 | 10.1021/jm020819i | Rattus norvegicus | 1 |
Data from ChEMBL 36 via Core Engine